Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
computational study suggests that although curcumin to some extent binds with Tp receptor (show TBXA2R Antibodies), yet the inhibition of Arf6GDP to Arf6GTP conversion appeared to be an important mechanism by which curcumin inhibits U46619-induced increase in PLD (show PLD Antibodies) activity in PASMCs.
Study discovered novel and independent associations of prediabetes and related traits with MASP1 (show MASP1 Antibodies), and some evidence for associations with THBS1 (show THBS1 Antibodies), GPLD1 and ApoA-IV (show APOA4 Antibodies), suggesting a role for these proteins in the pathophysiology of type 2 diabetes.
c-Myc (show MYC Antibodies) influences GPI (show GNPDA1 Antibodies)-AP signaling transcriptionally and posttranslational and represses GPI (show GNPDA1 Antibodies)-AP anti-proliferative signaling in tumors
An observed increase in PLD (show PLD Antibodies) activity was mediated through boosting the binding of PLD (show PLD Antibodies) with dynamin (show DNM1 Antibodies) which in turn facilitated fibronectin (show FN1 Antibodies)-induced cell spreading.
Low aggressive MCF-7 breast cancer cells have low endogenous PLD (show PLD Antibodies) enzymatic activity and cell invasion, concomitant with high expression of miR (show MLXIP Antibodies)-203, -887, and -3619 and miR (show MLXIP Antibodies)-182 and miR (show MLXIP Antibodies)-182.
suggest that the down-regulation of GPI-PLD protein may be involved in prion (show PRNP Antibodies) propagation in the brains of prion (show PRNP Antibodies) diseases
our findings showed that ANRIL is an lncRNA responsible in anti-tumorigenesis caused by PLD (show PLD Antibodies) inhibition and combined incorporation of ANRIL into PLD (show PLD Antibodies) inhibition-induced anti-tumorigenic signaling network
AMPK (show PRKAA1 Antibodies) suppresses PLD (show PLD Antibodies) activity, and PLD (show PLD Antibodies) suppresses AMPK (show PRKAA1 Antibodies) via mTOR (show FRAP1 Antibodies).
Functional regulation of phospholipase D (show PLD Antibodies) expression in cancer and inflammation.
Phospholipase D (show PLD Antibodies) and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR (show FRAP1 Antibodies)).
Overexpressing GPI-PLD in an insulinoma (show RPS15 Antibodies) cell line enhanced glucose-stimulated insulin (show INS Antibodies) secretion, suggesting that enhanced insulin (show INS Antibodies) secretion in vivo may have contributed to the improved glucose tolerance.
GPI-PLD expression was significantly increased in highly malignant. H-ras (show HRAS Antibodies)-transfected murine bladder carcinoma cells as compared to the low malignant, non-transfected parental cells.
His29, His125, His133 and His158 are required for GPI-PLD catalytic activity
Glycosylphosphatidylinositol-specific phospholipase D (show PLD Antibodies) influences triglyceride-rich lipoprotein metabolism.
Results suggest that cell-specific Gpld1- or peptidase-dependent pathways for prostasin (show PRSS8 Antibodies) secretion may control prostasin (show PRSS8 Antibodies) functions in a tissue-specific manner.
PLD (show PLD Antibodies) plays an important role in inflammatory responses and could be involved in a mechanism for the regulation of endothelial barrier function during hyperoxic lung injury
Many proteins are tethered to the extracellular face of eukaryotic plasma membranes by a glycosylphosphatidylinositol (GPI) anchor. The GPI-anchor is a glycolipid found on many blood cells. The protein encoded by this gene is a GPI degrading enzyme. Glycosylphosphatidylinositol specific phospholipase D1 hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans, thereby releasing the attached protein from the plasma membrane.
glycosylphosphatidylinositol specific phospholipase D1
, phosphatidylinositol-glycan-specific phospholipase D-like
, glycosylphosphatidylinositol specific phospholipase d1
, GPI-specific phospholipase D
, PI-G PLD
, glycoprotein phospholipase D
, phosphatidylinositol-glycan-specific phospholipase D
, glycosyl-phosphatidylinositol-specific phospholipase D
, glycosylphosphatidylinositol phospholipase D